← Leaderboards
Kenneth Allen Gruber
Tensive Controls, Inc.
$4,434,526
Attributed
$4,434,526
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2010–18$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$4,434,526 · 3
By mechanism
R44$4,235,181 · 2
R43$199,345 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Melanocortin Receptor”
- Joel K Elmquist · Beth Israel Deaconess Medical Center$14,634,759
- Roger D Cone · Oregon Health And Science University$12,905,461
- Carrie Haskell-Luevano · University Of Florida$12,811,742
- Christian Vaisse · University Of California San Francisco$11,217,253
- Bradford B Lowell · Food Allergy Science Initiative, Inc.$9,607,991
- Sharon L. Wardlaw · Columbia University Health Sciences$9,508,215
Research focus
Melanocortin ReceptorTherapeutic AgentsInflammatoryMalignant NeoplasmsPharmaceutical PreparationsSyndromeDesire For FoodHomeostasisDesignIn VivoMetabolicPeptidesPlayEatingCachexiaAnorexiaCardiovascular SystemFood Intake RegulationAdverse EffectsChronicCommunicable DiseasesComplicationAcuteAnimal Model
Grant awards (6)
Development of a Cancer Cachexia Therapeutic$1,415,204
R44 · FY2018 · CA · contact PI
Development of a Cancer Cachexia Therapeutic$898,017
R44 · FY2017 · CA · contact PI
Development of a Cancer Cachexia Therapeutic$204,519
R44 · FY2016 · CA · contact PI
Melanocortin Ligands in Disease Cachexia$820,563
R44 · FY2013 · CA · contact PI
Melanocortin Ligands in Disease Cachexia$896,878
R44 · FY2012 · CA · contact PI
Melanocortin Ligands in Disease Cachexia$199,345
R43 · FY2010 · CA · contact PI